Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis [Phase 2]
Phase 2 trial assessing atezolizumab plus stereotactic radiation for triple-negative breast cancer with brain metastases has completed enrol…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer [Phase 3]
Phase 3 trial results for S1207, comparing hormone therapy with and without everolimus, in breast cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and cyclophosphamide with or without trastuzumab before surgery in untreated breast cancer; results were…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Study of RC48-ADC in Subjects With Advanced Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating RC48-ADC in subjects with advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast [Phase 2]
Phase 2 clinical trial investigating neratinib's effect on live cell HER2 signaling in triple negative breast cancer contexts.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery [Phase 2]
Phase 2 clinical trial investigating TPIV100 in combination with sargramostim for HER2-positive breast cancer with residual disease after ch…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy [Phase 2]
Phase 2 clinical trial assessing indocyanine green (ICG) distribution in the margins after tumor resection for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 68-Ga-RM2 PET/MRI for imaging estrogen receptor-positive breast cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Palbociclib After CDK and Endocrine Therapy (PACE) [Phase 2]
Phase 2 trial update of Palbociclib for metastatic breast cancer after CDK and endocrine therapy. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial comparing oral AZD9833 (camizestrant) with intramuscular fulvestrant in postmenopausal women with advanced ER-positive HER2-ne…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery [Phase 3]
Phase 3 trial evaluating palbociclib added to standard endocrine therapy in HR-positive, HER2-normal breast cancer with residual disease aft…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients [Phase 2]
Phase II trial evaluating combination immunotherapy with NeuVax and Trastuzumab in high-risk HER2-positive breast cancer completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant [Phase 2]
Phase 2 trial evaluating safety and efficacy of adding dapagliflozin to extended-release metformin versus metformin XR alone in HR+, HER2-, …
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease [Phase 2]
Phase 2 clinical trial evaluating intra-hepatic chemotherapy for liver metastases from breast cancer with limited extrahepatic disease has c…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating elacestrant versus standard of care for ER+/HER2- advanced breast cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer
A completed clinical trial describing the breast cancer patient population, treatment, and results in Indian patients receiving combinations…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Aging Mammary Stem Cells and Breast Cancer Prevention [Phase 2]
Phase 2 clinical trial on aging mammary stem cells for breast cancer prevention was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 study evaluating talazoparib, radiotherapy, and atezolizumab in gBRCA1/2-negative, PD-L1 positive metastatic triple-negative breast …
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity [Phase 2]
A Phase 2 clinical trial evaluating monosialic gangliosides to prevent neurotoxicity from albumin-bound paclitaxel in early breast cancer ha…
-
CLINICAL_TRIALS research · 2023-12-04Clinical Trial Update: 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer [Phase 1, Phase 2]
A clinical trial update evaluating 16α-18F-fluor-17β-estradiol PET/CT to visualize estrogen receptor positive liver metastases in breast can…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Vitamin D and Calcium Supplementation in Breast Cancer [Phase 2, Phase 3]
A clinical trial update investigating the effect of vitamin D and calcium supplementation in patients with breast cancer across Phase 2 and …
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection [Phase 3]
A Phase 3 clinical trial evaluating regional anesthesia techniques for modified radical mastectomy with axillary lymph node dissection in br…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer [Phase 3]
Phase 3 clinical trial investigating Salovum™ and SPC-Flakes™ to mitigate abemaciclib-induced gastrointestinal toxicity in early breast canc…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating breast-conserving surgery plus radiation therapy for patients with multiple ipsilateral breast canc…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel plus radiation therapy in women with stage II or III breast cancer has completed.